Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

NorwayBack to Norway

Clinical trials in Haugesund

16 clinical trials in Haugesund, Norway across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

NorwayOur site in NorwayKliniske-Studier.no(opens in a new tab)
Haugesund at a glance
16
clinical trials
  • Paediatric trials0
  • Research sites2
Type of trial
Recruitment status
Quick filters

16 trials in Haugesund

Open in trial search

Chronic kidney disease

Recruiting

Randomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:AZD5004
  • Sponsor:AstraZeneca AB

Type 1 diabetes mellitus

Recruiting

A Study of Baricitinib to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes

Registered drug
Countries:NorwayNorway
  • Participants:0–17 years · 18–64 years
  • Substances:Baricitinib
  • Sponsor:Eli Lilly & Co.

Neoplasm malignant

Recruiting

Study on Dabrafenib, Trametinib, and Imatinib for Patients with Rare and Hard-to-Treat Cancers

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Dabrafenib
  • Sponsor:Oslo University Hospital HF

Neoplasm malignant

Recruiting

Study on the Effectiveness of Tepotinib and Drug Combination for Patients with Advanced Cancer

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Alpelisib
  • Sponsor:Oslo University Hospital HF

Immune thrombocytopenia

Recruiting

Study Comparing Avatrombopag and Rituximab for Adults with Immune Thrombocytopenia Not Responding to Corticosteroids

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Avatrombopag
  • Sponsor:Ostfold Hospital Trust

Cognitive disorder+1

Recruiting

Study on Fasudil Hydrochloride for Memory Loss Prevention in Early Alzheimer's Disease Patients

Investigational
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Fasudil Hydrochloride
  • Sponsor:Helse Stavanger HF

Osteoarthritis

Recruiting

Study on Painful Thumb Osteoarthritis: Comparing Triamcinolone Acetonide, Sodium Chloride, and Occupational Therapy for Patients with Inflammatory Thumb Joint Pain

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Diakonhjemmet Sykehus AS

Dementia with Lewy bodies

Recruiting

Study of Ambroxol Treatment in People with Early Stage or Mild Lewy Body Dementia

Investigational
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Ambroxol Hydrochloride
  • Sponsor:Helse Fonna HF

Small cell lung cancer limited stage

Not yet recruiting

Durvalumab after chemoradiation for patients with limited‑stage small cell lung cancer: a randomized trial of high‑dose versus standard thoracic radiation

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Norwegian University Of Science And Technolology

Cognitive disorder+1

Not recruiting

Study on the Effects of Phenserine and Donepezil in Patients with Early or Mild Alzheimer's Disease

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:(-)-Phenserine tartrate
  • Sponsor:Helse Stavanger HF

Breast cancer

Not recruiting

Study on Personalized Treatment for High-Risk Breast Cancer Using Palbociclib, Olaparib, and Pertuzumab in Patients with Advanced Disease

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Olaparib
  • Sponsor:Helse Bergen HF

Primary adrenal insufficiency

Not recruiting

Study on Quality of Life in Patients Aged 16-80 with Primary Adrenal Insufficiency Using Hydrocortisone (Plenadren) and Cortisone

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:0–17 years · 18–64 years
  • Substances:Cortisone
  • Sponsor:Helse Bergen HF

Other cities in Norway

The busiest research cities in the country

All 54 cities in Norway

Clinical research in Haugesund

What the registry says about research in the country

01 Oncology Research

Groundbreaking studies focusing on precision cancer medicine for various cancer types, including targeted therapies for breast cancer and advanced lung cancers.

  • Rare Cancer Treatment Options
  • Molecular Markers in Breast Cancer
  • Small-Cell Lung Cancer Therapy

Advanced research combining immunotherapy with conventional treatments to improve patient outcomes.

02 Neurological Disorders

Innovative clinical trials examining new treatments for Alzheimer's disease and other neurodegenerative conditions, including comparative studies of therapeutic approaches.

  • Early-Stage Alzheimer's Treatment
  • Multiple Sclerosis Management
  • Lewy Body Dementia Research

Emphasis on cognitive improvement and disease modification strategies.

03 Inflammatory Conditions

Comprehensive studies addressing rheumatoid arthritis and osteoarthritis, exploring innovative treatment monitoring and intervention strategies.

  • Therapeutic Drug Monitoring
  • Osteoarthritis Interventions
  • Immune Thrombocytopenia Studies

Focus on improving treatment efficacy and patient quality of life through targeted interventions.

Back to NorwayAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.